Human microRNA hsa-miR-125a-5p as biomarker for predicting late CMV infection in high-risk kidney transplant recipients
Transplant International · 20.11.2026 · 39
DOI: 10.3389/ti.2026.17587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 20.11.2026. Verfasst von Mario Fernández-Ruiz und 13 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Available strategies for predicting late-onset cytomegalovirus (CMV) infection in high-risk (seropositive donor/seronegative recipient [D+/R-]) kidney transplant recipients (KTRs) are suboptimal. We have previously shown that the expression level of human microRNA hsa-miR-125a-5p informs on the risk of CMV reactivation in seropositive (R+) KTRs. In the present work we assessed the predictive role of this microRNA in 50 consecutive D+/R- KTRs that received a 6-month course of valganciclovir prophylaxis. hsa-miR-125a-5p levels were measured by quantitative PCR in whole-blood samples obtained at the time of valganciclovir discontinuation. The cumulative incidence of late CMV infection through post-transplant month 12 was 46.0%. Patients who developed late CMV infection exhibited lower relative hsa-miR-125a-5p expression than those who remained free from this event (ΔCt values: 7.5 ± 1.3 vs. 6.7 ± 0.7, respectively; P -value = 0.005). The area under the receiver operating characteristic curve for predicting late CMV infection was 0.718 (95% confidence interval [CI]: 0.559–0.877). After multivariable adjustment, lower hsa-miR-125a-5p expression (ΔCt >7.623) was independently associated with the occurrence of late CMV infection (adjusted hazard ratio: 5.63; 95% CI: 2.28–13.91; P -value < 0.001). In conclusion, the relative expression of hsa-miR-125a-5p is useful to stratify the risk of late CMV infection in high-risk D+/R- KTRs.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Fernández-Ruiz, M., Membrillo-Solbes, P., Menéndez-Rodríguez, L., Pérez-Junquera, P., Rodríguez-Goncer, I., Ruiz-Merlo, T., Asín, M. A. P., López-Medrano, F., González, E., Sandino, J., Juan, R. S., Andrés, A., Aguado, J. M., & Redondo, N. (2026). Human microRNA hsa-miR-125a-5p as biomarker for predicting late CMV infection in high-risk kidney transplant recipients. Transplant International, 39. https://doi.org/10.3389/ti.2026.17587
Vancouver
Fernández-Ruiz M, Membrillo-Solbes P, Menéndez-Rodríguez L, Pérez-Junquera P, Rodríguez-Goncer I, Ruiz-Merlo T, et al. Human microRNA hsa-miR-125a-5p as biomarker for predicting late CMV infection in high-risk kidney transplant recipients. Transplant International. 2026;39. doi:10.3389/ti.2026.17587
BibTeX
@article{FernndezRuiz2026,
author = {Fernández-Ruiz, Mario and Membrillo-Solbes, Pilar and Menéndez-Rodríguez, Laura and Pérez-Junquera, Paula and Rodríguez-Goncer, Isabel and Ruiz-Merlo, Tamara and Asín, María Asunción Pérez-Jacoiste and López-Medrano, Francisco and González, Esther and Sandino, Justo and Juan, Rafael San and Andrés, Amado and Aguado, José María and Redondo, Natalia},
title = {Human microRNA hsa-miR-125a-5p as biomarker for predicting late CMV infection in high-risk kidney transplant recipients},
journal = {Transplant International},
year = {2026},
volume = {39},
doi = {10.3389/ti.2026.17587}
}
EUVIMED